Tag: skin patch
Company Receives $1.9 Million Grant to Advance Microneedle Patch Therapy for...
Grant will allow Moonlight Therapeutics to complete pre-clinical activities and submit and IND to the FDA.
FDA Advisory Committee Meeting to Review Viaskin Peanut for the Treatment...
Next step in the approval process for the therapy scheduled for May 15, 2020.
DBV Technologies Reports Positive Three-Year, Long Term Data from Phase III...
Patients demonstrated durable, long-term clinical benefit with an additional two years of treatment.
Peanut Patch Phase III Enrollment Ends, Results Expected Toward End of...
The study received higher-than-expected patient demand.
Study: EPIT (Skin Patch) Therapy Provides Sustained Protection Against Anaphylaxis
The unique immune communication between skin and gastrointestinal tract can be used to generate long-lasting protection from food allergies.
Viaskin Peanut, Milk and Egg Patch Therapies: Promising News from the...
We are cautiously optimistic that a safe, effective, easy to administer treatment for food allergy may be on the horizon.
Viaskin Milk Patch Receives Positive Recommendation to Proceed to Phase II
The board overseeing the Phase I study of the milk allergy therapy found no safety concerns.
Peanut Patch Receives FDA's Breakthrough Therapy Designation
The Viaskin Peanut patch received the BT designation after a positive Phase IIb trial.
